These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12065474)
1. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. Monari C; Kozel TR; Bistoni F; Vecchiarelli A Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474 [TBL] [Abstract][Full Text] [Related]
2. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans. Vecchiarelli A; Retini C; Casadevall A; Monari C; Pietrella D; Kozel TR Infect Immun; 1998 Sep; 66(9):4324-30. PubMed ID: 9712784 [TBL] [Abstract][Full Text] [Related]
3. Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling. Sun D; Zhang M; Liu G; Wu H; Zhu X; Zhou H; Shi M Infect Immun; 2016 Jan; 84(1):216-29. PubMed ID: 26502909 [TBL] [Abstract][Full Text] [Related]
4. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Dong ZM; Murphy JW Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584 [TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624 [TBL] [Abstract][Full Text] [Related]
6. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg). Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289 [TBL] [Abstract][Full Text] [Related]
7. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Gasque P; Singhrao SK; Neal JW; Götze O; Morgan BP Am J Pathol; 1997 Jan; 150(1):31-41. PubMed ID: 9006319 [TBL] [Abstract][Full Text] [Related]
8. Expression and function of C5a receptor in mouse microvascular endothelial cells. Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982 [TBL] [Abstract][Full Text] [Related]
9. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657 [TBL] [Abstract][Full Text] [Related]
10. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Wetsel RA Immunol Lett; 1995 Jan; 44(2-3):183-7. PubMed ID: 7797249 [TBL] [Abstract][Full Text] [Related]
11. Analysis of C5a receptor by monoclonal antibody. Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898 [TBL] [Abstract][Full Text] [Related]
12. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Dong ZM; Murphy JW Infect Immun; 1997 Feb; 65(2):557-63. PubMed ID: 9009313 [TBL] [Abstract][Full Text] [Related]
13. [The role of C5a in adhesion properties of polymorphonuclear leukocyte to pulmonary vascular endothelial cells in burn patients with acute lung injury]. Lu F; Zhu X; Hu C; Huang Y Zhonghua Shao Shang Za Zhi; 2002 Dec; 18(6):358-61. PubMed ID: 12641988 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437 [TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships of human C5a and C5aR. Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141 [TBL] [Abstract][Full Text] [Related]
16. Effects of the two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Dong ZM; Murphy JW Infect Immun; 1995 Jul; 63(7):2632-44. PubMed ID: 7790079 [TBL] [Abstract][Full Text] [Related]
17. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070 [TBL] [Abstract][Full Text] [Related]
18. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091 [TBL] [Abstract][Full Text] [Related]
19. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus]. Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327 [TBL] [Abstract][Full Text] [Related]
20. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]